M. Posner

Cisplatin and fluorouracil alone or with docetaxel in head and neck cancer.

A. Markoe, R. Tishler, D. Shin, 2007, The New England journal of medicine.

Sequential therapy for the locally advanced larynx and hypopharynx cancer subgroup in TAX 324: survival, surgery, and organ preservation.

R. Tishler, D. Shin, L. Raez, 2009, Annals of oncology : official journal of the European Society for Medical Oncology.

An initial experience using concurrent paclitaxel and radiation in the treatment of head and neck malignancies.

R. Tishler, P. Busse, E. Peters, 1999, International journal of radiation oncology, biology, physics.

Induction chemotherapy with docetaxel, cisplatin, fluorouracil, and leucovorin for squamous cell carcinoma of the head and neck: a phase I/II trial.

S. Adak, R. Tishler, R. Fabian, 1998, Journal of clinical oncology : official journal of the American Society of Clinical Oncology.

Phase I/II Trial of Outpatient Docetaxel, Cisplatin, 5-Fluorouracil, Leucovorin (opTPFL) as Induction for Squamous Cell Carcinoma of the Head and Neck (SCCHN)

S. Adak, R. Tishler, M. Posner, 2002, American journal of clinical oncology.

Integrating systemic agents into multimodality treatment of locally advanced head and neck cancer.

M. Posner, 2010, Annals of oncology : official journal of the European Society for Medical Oncology.

Results of a phase II study evaluating monalizumab in combination with cetuximab in previously treated recurrent or metastatic squamous cell carcinoma of the head and neck (R/M SCCHN).

S. Salas, T. Seiwert, R. Cohen, 2018, Annals of Oncology.

Clinical pharmacokinetics of 3-day continuous infusion cisplatin and daily bolus 5-Fluorouracil

M. Posner, M. Wiemann, P. Calabresi, 2004, European Journal of Clinical Pharmacology.

Docetaxel in head and neck cancer: a review.

M. Posner, A. D. Colevas, A. Colevas, 1998, American journal of clinical oncology.